Basic Insights into Tumor Microenvironment in Prostate Cancer
Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy, Page: 43-71
2024
- 2Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures2
- Readers2
Book Chapter Description
Prostate cancer, a prominent malignancy impacting men worldwide, is characterized by a dynamic and intricate interplay between cancer cells and their surrounding microenvironment. The unique signature of the malignant transformation process arose from the inherent specificity of the prostate tissue and its function in semen fluid production. Unlike other cancer types where the shift to glycolytic energy supply is a hallmark of the neoplastic alteration, prostate cancer operates on entirely opposing principles. Focused on citrate production for seminal fluid, normal prostate epithelial cells function in a reduced oxidative phosphorylation (OXPHOS) manner. In the process of neoplastic transformation, cells redirect citrate into the Krebs cycle, converting inefficient to energy-efficient metabolism. From tumor initiation to metastasis, the distinct tumor microenvironment (TME), constituted of cellular and noncellular components, shapes the process of malignant transformation, rendering it increasingly aggressive, with immune system cells playing a pivotal role in connecting all these stages. This review will comprehensively elaborate the sophisticated and dynamic communication, enormous cellular plasticity and tissue flexibility leading to successive modifications of all structures, and their profound influence on disease progression.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=105001901145&origin=inward; http://dx.doi.org/10.1007/978-3-031-51712-9_3; https://link.springer.com/10.1007/978-3-031-51712-9_3; https://dx.doi.org/10.1007/978-3-031-51712-9_3; https://link.springer.com/chapter/10.1007/978-3-031-51712-9_3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know